Pfizer, Tempus collaborate on cancer drug development
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multiyear strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology. Pfizer will leverage Tempus’ library of de-identified data to accelerate therapeutic development in oncology. It will also use Tempus’ AI-driven companion diagnostic offerings and clinical […]